Glycemic Variability in Intermittent Fasting
GLUInterm
Effect of Intermittent Fasting on Glycaemic Variability in Healthy Subjects
1 other identifier
interventional
10
1 country
1
Brief Summary
The aim was to test the difference in glycemic variability after meal consumption during intermittent fasting and the usual diet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 16, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 2, 2021
CompletedFirst Submitted
Initial submission to the registry
March 28, 2023
CompletedFirst Posted
Study publicly available on registry
April 10, 2023
CompletedApril 10, 2023
March 1, 2023
2 months
March 28, 2023
March 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Blood glucose
Change in blood glucose
3 days per protocol
Glycemic variability
Coefficient of Variation expressed as the ratio between standard deviation and mean blood glucose
3 days per protocol
Study Arms (2)
Intermittent Fasting
EXPERIMENTALControl Diet
PLACEBO COMPARATORInterventions
Participants received a 3-day individualized diet plan consisting of 3 meals per day. Meals needed to be consumed during 6 hours (while fasting for the remaining 18 hours). Diet plans were matched for energy and macronutrients.
Participants received a 3-day individualized diet plan consisting of 3 meals per day. Meals needed to be consumed during 12 hours (while fasting for the remaining 12 hours). Diet plans were matched for energy and macronutrients.
Eligibility Criteria
You may qualify if:
- Body Mass Index in the range between 18.5 and 29.9 kg/m\^2
- stable sleep pattern (going to bed between 21:30h and midnight)
- for women: regular menstrual cycle lasting between 21 and 35 days, with average bleeding time 2 to 6 days
You may not qualify if:
- Body Mass Index below 18.5 or above 29.9 kg/m\^2
- irregular sleeping pattern
- work in nightshift
- high intensity workout routine
- irregular dietary patterns (e.g. skipping meals)
- regularly fasting for more than 15 hours per day
- diagnosis of diabetes (or other conditions related to glycemic disorders)
- hypertension or other cardiovascular disease
- neurologic conditions
- disease affecting metabolism (like liver, kidney, thyroid or lung)
- use of medications for glycemia, hypertension, steroids, adrenergic stimulators, laxatives or supplements affecting glycemia, circadian rhythm, sleep or metabolism in general
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Food and Nutrition Research, Faculty of Food Technology
Osijek, 31000, Croatia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ines Banjari, PhD
University of Osijek, Croatia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Clinical Nutrition Specialist
Study Record Dates
First Submitted
March 28, 2023
First Posted
April 10, 2023
Study Start
January 26, 2021
Primary Completion
March 16, 2021
Study Completion
June 2, 2021
Last Updated
April 10, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share
All the results will be published (as journal manuscript) and freely accessible to all interested parties. Also, interested parties can contact investigators for any details regarding the study and results (for example if individual data is required for a meta-analysis).